The uncertainty of future earnings has clouded the company's intrinsic value.
Bank tellers don't make a lot of money despite sky-high executive pay and record industry profits. Are the banks to blame, or are there bigger forces at work?
And not just for the holidays, either, but to own for years.
Forest Laboratories makes significant company improvements as AstraZeneca considers possible buyout.
The biggest stories from Wednesday’s world of finance.
Could a mere job listing point to a revenue driver for Apple? What Apple, Google, and eBay investors should know about this opportunity.
EU announces fines against Deutsche Bank, RBS, JPMorgan Chase, Citigroup, and others for their role in manipulating LIBOR.
The OncoMed and Celgene partnership was unexpected and has created large returns for shareholders, but who does it really benefit in the long term?
Buffett's price floor in Berkshire shares should keep it from ever becoming "cheap" again.
In a new ad from Amazon, the company pokes fun at Apple's iPad Air. Will an assault on Apple work for Amazon?